SCHEMBL4630985

SCHEMBL4630985

COCCCCN1CCNCC1[C]=O

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2701361 0.95 MEN1 (0.32) MEN1KMT2A
SCHEMBL4630109 0.89 GBA1 (0.33) MEN1KMT2A
SCHEMBL19812633 0.82 GNAO1 (0.39)
SCHEMBL4630454 0.82 GNAO1 (0.39)
SCHEMBL4630349 0.81 TAAR1 (0.35) MEN1KMT2A
SCHEMBL15217037 0.78 QPCT (0.34) MEN1KMT2A
SCHEMBL15217038 0.78 QPCT (0.34) MEN1KMT2A
SCHEMBL4630211 0.78 TAAR1 (0.34)
SCHEMBL4630216 0.74
SCHEMBL4659262 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1919907-A2 HETEROCYCLIC COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-05-14 EP disclosed
WO-2007026959-A2 DERIVATIVES OF 4-PIPERAZIN-1-YL-4-BENZ0 [B] THIOPHENE SUITABLE FOR THE TREATMENT OF CNS DISORDERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-03-08 WO disclosed